Skip to main content
PMC home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1974 Jun;37(6):715–718. doi: 10.1136/jnnp.37.6.715

Amine metabolites in the cerebrospinal fluid of patients with disseminated sclerosis

L E Claveria 1,1, G Curzon 1, M J G Harrison 1,2, B D Kantamaneni 1
PMCID: PMC494753  PMID: 4844138

Abstract

Mean homovanillic acid and 5-hydroxyindoleacetic acid concentrations were significantly low in the lumbar CSF of a group of patients with disseminated sclerosis (DS) who were severely disabled but not in the CSF of a less severely restricted group with DS. CSF concentrations were also low in a group of patients with superior cerebellar peduncular tremor due to DS and in a single patient with a similar tremor associated with a post-traumatic brain-stem lesion. The interpretation of abnormal CSF amine metabolite concentrations is discussed in the light of these findings.

Full text

PDF
715

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BONDUELLE M. Les tremblements; etude séméiologique et nosologique. Rev Neurol (Paris) 1952;86(6):567–658. [PubMed] [Google Scholar]
  2. Bernheimer H., Birkmayer W., Hornykiewicz O. Homovanillinsäure im Liquor cerebrospinalis: Untersuchungen beim Parkinson-Syndrom und anderen Erkrankungen des ZNS. Wien Klin Wochenschr. 1966 Jun 10;78(23):417–419. [PubMed] [Google Scholar]
  3. Bliss E. L., Ailion J. Relationship of stress and activity to brain dopamine and homovanillic acid. Life Sci I. 1971 Oct 15;10(20):1161–1169. doi: 10.1016/0024-3205(71)90276-1. [DOI] [PubMed] [Google Scholar]
  4. Bowers M. B., Jr Deficient transport mechanism for the removal of acid monoamine metabolites from cerebrospinal fluid. Brain Res. 1969 Oct;15(2):522–524. doi: 10.1016/0006-8993(69)90174-7. [DOI] [PubMed] [Google Scholar]
  5. Brody J. A., Chase T. N., Gordon E. K. Depressed monoamine catabolite levels in cerebrospinal fluid of patients with parkinsonism dementia of Guam. N Engl J Med. 1970 Apr 23;282(17):947–950. doi: 10.1056/NEJM197004232821704. [DOI] [PubMed] [Google Scholar]
  6. Curzon G., Gumpert J., Sharpe D. Amine metabolites in the cerbrospinal fluid in Huntington's chorea. J Neurol Neurosurg Psychiatry. 1972 Aug;35(4):514–519. doi: 10.1136/jnnp.35.4.514. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Curzon G. Involuntary movements other than Parkinsonism: biochemical aspects. Proc R Soc Med. 1973 Sep;66(9):873–876. [PMC free article] [PubMed] [Google Scholar]
  8. EHRINGER H., HORNYKIEWICZ O. [Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system]. Klin Wochenschr. 1960 Dec 15;38:1236–1239. doi: 10.1007/BF01485901. [DOI] [PubMed] [Google Scholar]
  9. Godwin-Austen R. B. Kantamaneni BD, Curzon G:Comparison of benefit from L-dopa in Parkinsonism with increase of amine metabolites in the CSF. J Neurol Neurosurg Psychiatry. 1971 Jun;34(3):219–223. doi: 10.1136/jnnp.34.3.219. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Mendell J. R., Chase T. N., Engel W. K. Amyotrophic lateral sclerosis. A study of central monoamine metabolism and therapeutic trial of levodopa. Arch Neurol. 1971 Oct;25(4):320–325. doi: 10.1001/archneur.1971.00490040046006. [DOI] [PubMed] [Google Scholar]
  11. Mendell J. R., Engel W. K., Chase T. N. Modification by L-dopa of a case of progressive supranuclear palsy. With evidence of defective cerebral dopamine metabolism. Lancet. 1970 Mar 21;1(7647):593–594. doi: 10.1016/s0140-6736(70)91629-6. [DOI] [PubMed] [Google Scholar]
  12. Moir A. T., Ashcroft G. W., Crawford T. B., Eccleston D., Guldberg H. C. Cerebral metabolites in cerebrospinal fluid as a biochemical approach to the brain. Brain. 1970;93(2):357–368. doi: 10.1093/brain/93.2.357. [DOI] [PubMed] [Google Scholar]
  13. Olsson R., Roos B. E. Concentrations of 5-hydroxyindoleacetic acid and homovanillic acid in the cerebrospinal fluid after treatment with probenecid in patients with Parkinson's disease. Nature. 1968 Aug 3;219(5153):502–503. doi: 10.1038/219502a0. [DOI] [PubMed] [Google Scholar]
  14. Post R. M., Kotin J., Goodwin F. K., Gordon E. K. Psychomotor activity and cerebrospinal fluid amine metabolites in affective illness. Am J Psychiatry. 1973 Jan;130(1):67–72. doi: 10.1176/ajp.130.1.67. [DOI] [PubMed] [Google Scholar]
  15. Pullar I. A., Weddell J. M., Ahmed R., Gillingham F. J. Phenolic acid concentrations in the lumbar cerebrospinal fluid of Parkinsonian patients treated with L-dopa. J Neurol Neurosurg Psychiatry. 1970 Dec;33(6):851–857. doi: 10.1136/jnnp.33.6.851. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Sonninen V., Riekkinen P., Rinne U. K. Acid monoamine metabolites in cerebrospinal fluid in multiple sclerosis. Neurology. 1973 Jul;23(7):760–763. doi: 10.1212/wnl.23.7.760. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES